HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of SARS-CoV-2-specific antibodies in COVID-19 patients reveals highly potent neutralizing IgA.

AuthorsWeihong Zeng, Huan Ma, Chengchao Ding, Yunru Yang, Yong Sun, Xiaoxue Huang, Weihuang He, Yan Xiang, Yong Gao, Tengchuan Jin
JournalSignal transduction and targeted therapy (Signal Transduct Target Ther) Vol. 6 Issue 1 Pg. 35 (01 29 2021) ISSN: 2059-3635 [Electronic] England
PMID33514692 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Immunoglobulin A
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
Topics
  • Antibodies, Neutralizing (immunology)
  • Antibodies, Viral (immunology)
  • COVID-19 (immunology)
  • Humans
  • Immunoglobulin A (immunology)
  • SARS-CoV-2 (immunology)
  • Spike Glycoprotein, Coronavirus (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: